These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9700989)

  • 1. Vascular and cardiac effects of DV-7028, a selective, 5-HT2-receptor antagonist in rats.
    Pawlak D; Adamkiewicz M; Malyszko J; Takada A; Mysliwiec M; Buczko W
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):266-73. PubMed ID: 9700989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats.
    Pawlak D; Małyszko J; Myśliwiec M; Takada A; Buczko W
    Acta Physiol Hung; 1996; 84(3):325-6. PubMed ID: 9219625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
    Pawlak D; Pawlak K; Chabielska E; Małyszko J; Takada A; Myśliwiec M; Buczko W
    Thromb Res; 1998 Jun; 90(6):259-70. PubMed ID: 9700856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.
    Shibano T; Tanaka T; Morishima Y; Yasuoka M; Watanabe K; Fujii F
    Arch Int Pharmacodyn Ther; 1992; 319():114-28. PubMed ID: 1285670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of the 5-HT2 receptor antagonist DV-7028 and aspirin or heparin on coronary cyclic flow reductions in dogs.
    Tanaka T; Morishima Y; Watanabe K; Shibutani T; Yasuoka M; Shibano T
    Cardiovasc Res; 1993 Jul; 27(7):1374-9. PubMed ID: 8252602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST; Lewis SJ; Brody MJ; Gebhart GF
    Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
    Kalkman HO; Engel G; Hoyer D
    J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of acetaldehyde on the vasopressor effect of serotonin in pithed rats.
    Pawlak D; Krygicz D; Chabielska E; Buczko W
    Alcohol Alcohol; 1992 Jul; 27(4):367-72. PubMed ID: 1418111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep.
    Nelson M; Coghlan JP; Denton DA; Tresham JJ; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1987 Jul; 14(7):555-63. PubMed ID: 3124998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.
    Smits J; van Dorsten F; Struyker Boudier H
    Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    Docherty JR
    J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and 5-HT2 antagonist activity of bicyclic 1,2,4-triazol-3(2H)-one and 1,3,5-triazine-2,4(3H)-dione derivatives.
    Watanabe Y; Usui H; Kobayashi S; Yoshiwara H; Shibano T; Tanaka T; Morishima Y; Yasuoka M; Kanao M
    J Med Chem; 1992 Jan; 35(1):189-94. PubMed ID: 1732528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.